Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03465540
Title Safety, Tolerability, Pharmacokinetics and Efficacy of AMG 397 in Subjects With Selected Relapsed or Refractory Hematological Malignancies
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Amgen
Age Groups: adult | senior
Covered Countries USA | ITA | FRA | AUS

No variant requirements are available.